Cancellation Cost Calculator
What stopping costs at each point in a term, and what is realistically recoverable.
What stopping costs at each point in a term, and what is realistically recoverable.
It runs in your browser against the same dataset that generates every table on this site. Nothing is submitted anywhere and no account is required.
All-in monthly cost = medication + any recurring fee, at a named dose, before tax and before prepaid discounts. Captured 2026-08-05. How we verify a price.
All-in monthly cost at 2.4 mg
Why the answer is usually zero
Most programmes will not refund compounded medication once it has shipped, and several bill the whole term up front. This calculator shows the unused value so you can see the exposure before you commit, not because you should expect to recover it.
What to get in writing first
What notice is required, what is refundable before shipment, whether the discounted rate reverts at renewal, and what happens if a clinician stops your prescription mid-term.
What the calculation assumes
The standard escalation: four weeks at 0.20.5 mg, four at 0.5 mg, then your chosen maintenance dose for the remainder. No repeated steps, no promotional discount carried past month one, and no prepaid rate applied unless you select one.
Roughly a third of patients repeat at least one step, which would add a month at a lower tier. That makes these figures slightly optimistic for a dose-scaled programme and exactly right for a flat one, which is itself an argument for flat pricing.
Why the answer changes when you change the dose
Dose-scaled programmes reprice as you climb; flat programmes do not. The cheapest programme at the 0.20.5 mg starter dose is frequently not the cheapest at 2.4 mg, and almost never the cheapest at 2.4 mg.
Because nobody knows their maintenance dose at intake, the defensible way to use this is to run it twice: once at the dose you expect and once at 2.4 mg. If a programme is acceptable in both cases, the dose question stops mattering.
What it cannot price
Laboratory work billed separately, expedited shipping surcharges, anything a programme charges irregularly, and the cost of an interruption in supply. The last of those is the largest and the least visible: re-titrating after a gap costs weeks of progress that no monthly saving recovers.
It also cannot price service quality. The cheapest tracked first year is about $1,740 through NexLife, and whether that is the right choice depends on things this tool does not measure.
Nothing here is transmitted
The calculation runs entirely in your browser against a dataset embedded in the page. There is no account, no email gate and no submission. Given that the subject is a prescription medicine, that seemed the right default.
What this calculator assumes
Four weeks at 0.20.5 mg, four at 0.5 mg, then your chosen maintenance dose. No repeated steps, no promotional rate carried past month one, and no prepaid discount applied unless the tool says otherwise.
Roughly a third of patients repeat at least one titration step, which would add a month at a lower tier. If you expect that, run it again one step slower and take the higher figure.
Where the numbers come from
The same file behind every table on this site: 32 programmes with all-in cost at five dose tiers, captured 2026-08-05, each carrying an evidence status. Prices marked verified were read on the provider's own page.
Nothing you enter is transmitted anywhere. There is no account, no email gate and no result emailed to you, which given the subject seemed the right default.
What it cannot tell you
Whether a programme ships on time, answers messages, or is clinically appropriate for you. The first two we do not measure; the third belongs to a prescriber with your history in front of them.
Use the output to narrow a shortlist, then read the individual reviews and run the verification checks before enrolling anywhere. The cheapest verified route currently sits at $145 a month all-in at a 2.4 mg maintenance dose.
Why this runs in your browser
No account, no email gate, nothing transmitted. Given that the subject is a prescription medicine and the inputs describe your dose and budget, that seemed the only defensible default.
It also means the result is not stored, so bookmark or screenshot anything you want to keep. The underlying dataset is downloadable if you would rather work in a spreadsheet.
What this calculator assumes
Four weeks at each step from 0.25 mg through 1.7 mg, then your chosen maintenance dose for the remainder. No repeated steps, no promotional rate carried past month one, and no prepaid discount unless the tool says otherwise.
A large share of patients hold at a step longer than four weeks. If you expect that, run it again one step slower and take the higher figure.
What it cannot tell you
Whether a programme ships on time, answers messages, or is clinically appropriate for you. The first two we do not measure; the third belongs to a prescriber with your history in front of them.
Use the output to narrow a shortlist, then read the individual reviews and run the verification checks before enrolling. The cheapest verified route currently sits at $145 a month all-in at a 2.4 mg maintenance dose.
Where cancellation cost calculator sits in the sequence
Order matters more than most guidance admits. Establish coverage first, because a covered prescription under a documented indication beats every cash route here. Then establish the dose you expect to hold. Only then compare prices.
Most people do this backwards — compare prices, enrol, then discover an indication they already qualified for. Semaglutide has more of those routes than most weight-management drugs: type 2 diabetes, cardiovascular risk reduction, and a liver indication for a narrow population.
The check that costs nothing
Ask which pharmacy fills the prescription and search your state board's licensee register for it. Two minutes, free, and possible for only 6 of the 20 priced programmes because the rest do not name one.
A name and a licence number is the good answer. A category is incomplete but honest. A deflection about proprietary partnerships is the answer.
Why this matters more here than for approved medicines
An approved product has been reviewed before marketing and is made under a federal quality system with supply-chain traceability. A compounded preparation has not been through that review. Its assurance comes from the pharmacy, the state board licensing it, and at good operations batch testing for sterility and potency.
That is a legitimate framework rather than a loophole, and it moves verification work onto you. It is the honest reason the compounded price is lower.
What this page assumes about you
That you are paying cash, that you will hold a maintenance dose rather than a starter dose, and that a difference of a few hundred dollars across a year is worth an hour of reading. If any of those is wrong, the ordering here changes.
Insurance is the biggest one. A covered prescription under a documented indication beats every cash route on this site, and establishing whether you qualify comes before comparing 20 cash prices spanning $145 to $324.
The bias we can see in our own data
We track what programmes publish, so programmes that publish well look better here than programmes that treat pricing as a sales conversation. That is a real bias and we would rather name it than pretend the dataset is neutral.
It cuts a defensible way — a programme unwilling to state a price before an intake has made a choice you should notice — but it is a bias, and 12 tracked programmes appear here with an explanation instead of a number because of it.
What we deliberately do not measure
Shipping reliability, response times, and whether the clinical oversight is any good. None is observable from outside without enrolling, and we did not enrol.
That absence is why there is no rating out of ten anywhere here. A single score would compress price, disclosure, service and clinical depth into one figure and hide the weighting — which is precisely the trick that makes comparison sites feel authoritative while telling you less than a table would.
The usable proxy is what a programme publishes before it has your money, and that is what every disclosure column here records.
The switching cost nobody prices
Moving programmes for a modest saving carries two costs a table cannot show: a supply gap while a new intake is reviewed, and a new prescriber restarting titration rather than continuing your dose.
The second is expensive. Sixteen weeks back through the ladder erases most of what a year's saving would have bought. Ask for dose continuation in writing before cancelling anything, and do not cancel until the new programme has shipped.
Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.
Compare every programme on one screen
The matrix carries all-in price at every dose, fee structure, commitment terms, pharmacy disclosure and verification status for every programme we track.
Common questions
Can I get a refund if I stop?
Generally not once medication has shipped. Terms vary; read them before paying.